Jian Irish

Insider Reports History

Location
Emeryville, CA
Signature
/s/ Matthew L. Wein, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jian Irish:

Company Role Class Num Shares Value Price $ Report Date Ownership
Metagenomi Therapeutics, Inc. Chief Executive Officer, Director Common Stock 333,770 $534,032 $1.60 05 Mar 2026 Direct
Metagenomi Therapeutics, Inc. Chief Executive Officer, Director Common Stock 292,713 $424,433 $1.45 05 Dec 2025 By Trust
Metagenomi, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 225,000 01 Dec 2025 Direct

Insider Reports Filed by Jian Irish

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MGX Metagenomi Therapeutics, Inc. 05 Dec 2025 2 -$2,571 4 Chief Executive Officer, Director 09 Mar 2026, 17:15
MGX Metagenomi, Inc. 05 Dec 2025 1 -$2,839 4 Chief Executive Officer, Director 08 Dec 2025, 13:38
MGX Metagenomi, Inc. 05 Sep 2025 4 +$394,700 4 Chief Executive Officer, Director 01 Dec 2025, 19:28
MGX Metagenomi, Inc. 06 Jun 2025 1 -$11,182 4 Title: President and Chief Operating Officer, Director 09 Jun 2025, 18:20
MGX Metagenomi, Inc. 01 Apr 2025 2 $0 4 Title: President and Chief Operating Officer, Director 03 Apr 2025, 11:57
MGX Metagenomi, Inc. 01 Apr 2024 2 $0 4 Title: President and Chief Operating Officer, Director 03 Apr 2024, 21:10
MGX Metagenomi Technologies, LLC 08 Feb 2024 0 $0 3 Title: President and Chief Operating Officer; Exhibit 24 - Power of Attorney, Director 08 Feb 2024, 19:11